DISCOUNT ZERTIFIKAT - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 11:34:17 20/06/2024 pm IST | ||
| 37.23 EUR | +0.92% |
|
| Current month | +2.62% | ||
| 1 month | +2.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 20/24/20 | 37.23 | +0.92% |
| 19/24/19 | 36.89 | -0.46% |
| 18/24/18 | 37.06 | -0.05% |
| 17/24/17 | 37.08 | -0.38% |
| 14/24/14 | 37.22 | +0.49% |
Delayed Quote Deutsche Boerse AG
Last update June 20, 2024 at 11:34 pm IST
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VM5UQ2 |
| ISIN | DE000VM5UQ23 |
| Date issued | 22/11/2023 |
| Maturity | Today (1 Days) |
| Parity | 1 : 1 |
| Emission price | 35.22 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 37.23 € |
|---|---|
| Lowest since issue | 34.52 € |
| Spread | -0.07 € |
| Spread % | 0.19% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.04
USD
Average target price
53.19
USD
Spread / Average Target
+29.62%
- Stock Market
- Certificates
- Certificat
